Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
On Friday, an FDA advisory panel concluded a pivotal two-day session that could redefine the...
On Friday, an FDA advisory panel concluded a pivotal two-day session that could redefine the...
Chinese AI startup Moonshot AI, renowned for its increasingly popular "Kimi K" family of powerful,...
The transition marks the end of the Ingram era, a period defined by Sarepta’s transformation...
The intricate balance of the oral environment is crucial for maintaining dental health. Tooth enamel,...
For Discover cardholders, the most immediate change will be the platform through which they manage...
The journey of Kalshi, a CFTC-regulated prediction market exchange, into the realm of flight cancellation...
For nearly three-quarters of a century, the medical science of limb lengthening has occupied a...
Weeks before its anticipated acquisition by SpaceX, valued at an immense $60 billion in an...
Toronto is grappling with a fresh wave of violence after the United States consulate was...
Microsoft has ignited a new battlefront in the escalating AI security wars, unveiling a groundbreaking...